Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women

International Journal of Colorectal Disease

Volumn 28, Issue 12, 2013, Pages 1637-1642

  Phipps, Amanda I ^a   Makar, Karen W ^a   Newcomb, Polly A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Colorectal cancer; KRAS; PIK3CA; Survival

Indexed keywords

B RAF KINASE; DNA;

ADULT; AGED; ARTICLE; BRAF GENE; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SPECIFIC SURVIVAL; EXON; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIFESTYLE; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MIDDLE AGED; ONCOGENE K RAS; OVERALL SURVIVAL; PHOSPHOINOSITIDE 3 KINASE CATALYTIC ALPHA POLYPEPTIDE GENE; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR INVASION; UNITED STATES; WILD TYPE;

AGED; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; POSTMENOPAUSE;

EID: 84889888540     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1715-8     Document Type: Article

References (24)

1. Nosho K, Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Zepf D et al (2008) PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. Neoplasia 10:534-541
2. Liao X, Morikawa T, Lochhead P, Imamura Y, Kuchiba A, Yamauchi M et al (2012) Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review. Clin Cancer Res 18:2257-2268
3. Whitehall VL, Rickman C, Bond CE, Ramsnes I, Greco SA, Umapathy A et al (2012) Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int J Cancer 131:813-820
4. Ogino S, Nosho K, Kirkner GJ, Shima K, Irahara N, Kure S et al (2009) PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J Clin Oncol 27:1477-1484
5. Velho S, Oliveira C, Ferreira A, Ferreira AC, Suriano G, Schwartz S Jr et al (2005) The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 41:1649-1654
6. Li HT, Lu YY, An YX, Wang X, Zhao QC (2011) KRAS, BRAF and PIK3CA mutations in human colorectal cancer: relationship with metastatic colorectal cancer. Oncol rep 25:1691-1697
7. De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G et al (2010) Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol 11:753-762
8. Samuels Y, Velculescu VE (2004) Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3:1221-1224
9. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261-1274
10. Newcomb PA, Zheng Y, Chia VM, Morimoto LM, Doria-Rose VP, Templeton A, Thibodeau SN, Potter JD (2007) Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 67:7534-7539
11. Ligresti G, Militello L, Steelman LS, Cavallaro A, Basile F, Nicoletti F, Stivala F, McCubrey JA, Libra M (2009) PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches. Cell Cycle 8:1352-1358
12. Baker CL, Vaughn CP, Samowitz WS (2012) A PIK3CA pyrosequencing-based assay that excludes pseudogene interference. J Mol Diagn 14:56-60
13. Oliner K, Juan T, Suggs S, Wolf M, Sarosi I, Freeman DJ et al (2010) A comparability study of 5 commercial KRAS tests. Diagn Pathol 5:23
14. Alsop K, Mead L, Smith LD, Royce SG, Tesoriero AA, Young JP et al (2006) Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer 42:1357-1361
15. Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR et al (2010) Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One 5:e11636
16. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW et al (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257
17. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787-793
18. World Health Organization (2000) International classification of diseases for oncology. WHO, Geneva
19. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) AJCC cancer staging handbook, 6th edn. Springer, New York
20. World Health Organization (2007) International classification of diseases. WHO, Geneva
21. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, New York
22. Schubbert S, Shannon K, Bollag G (2007) Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7:295-308
23. Zhao L, Vogt PK (2008) Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc Natl Acad Sci U S A 105:2652-2657
24. Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S et al (2012) KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. PLoS One 7:e38033